These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 21489024)

  • 21. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
    Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
    J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The human ether-a-go-go-related gene (hERG) current inhibition selectively prolongs action potential of midmyocardial cells to augment transmural dispersion.
    Yasuda C; Yasuda S; Yamashita H; Okada J; Hisada T; Sugiura S
    J Physiol Pharmacol; 2015 Aug; 66(4):599-607. PubMed ID: 26348084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applications.
    Thomas D; Karle CA; Kiehn J
    Curr Pharm Des; 2006; 12(18):2271-83. PubMed ID: 16787254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656.
    Ridley JM; Milnes JT; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2004 Dec; 325(3):883-91. PubMed ID: 15541373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric modulators of the hERG K(+) channel: radioligand binding assays reveal allosteric characteristics of dofetilide analogs.
    Yu Z; Klaasse E; Heitman LH; Ijzerman AP
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):78-86. PubMed ID: 24200993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of a compound that protects cardiac tissue from human Ether-à-go-go-related gene (hERG)-related drug-induced arrhythmias.
    Potet F; Lorinc AN; Chaigne S; Hopkins CR; Venkataraman R; Stepanovic SZ; Lewis LM; Days E; Sidorov VY; Engers DW; Zou B; Afshartous D; George AL; Campbell CM; Balser JR; Li M; Baudenbacher FJ; Lindsley CW; Weaver CD; Kupershmidt S
    J Biol Chem; 2012 Nov; 287(47):39613-25. PubMed ID: 23033485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of DC031050, a class III antiarrhythmic agent, on hERG channel and three neuronal potassium channels.
    Li P; Sun HF; Zhou PZ; Ma CY; Hu GY; Jiang HL; Li M; Liu H; Gao ZB
    Acta Pharmacol Sin; 2012 Jun; 33(6):728-36. PubMed ID: 22609836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of hERG K
    Abramochkin DV; Pustovit OB; Mironov NY; Filatova TS; Nesterova T
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5093-5104. PubMed ID: 38224347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions at human ether-à-go-go-related gene channels.
    Friemel A; Zünkler BJ
    Toxicol Sci; 2010 Apr; 114(2):346-55. PubMed ID: 20071423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [3H]dofetilide binding in SHSY5Y and HEK293 cells expressing a HERG-like K+ channel?
    Finlayson K; Pennington AJ; Kelly JS
    Eur J Pharmacol; 2001 Feb; 412(3):203-12. PubMed ID: 11166283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclovirobuxine D inhibits the currents of HERG potassium channels stably expressed in HEK293 cells.
    Zhao J; Wang Q; Xu J; Zhao J; Liu G; Peng S
    Eur J Pharmacol; 2011 Jun; 660(2-3):259-67. PubMed ID: 21497594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Block of HERG-carried K+ currents by the new repolarization delaying agent H 345/52.
    Amos GJ; Jacobson I; Duker G; Carlsson L
    J Cardiovasc Electrophysiol; 2003 Jun; 14(6):651-8. PubMed ID: 12875428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facilitation of
    Furutani K; Tsumoto K; Chen IS; Handa K; Yamakawa Y; Sack JT; Kurachi Y
    J Gen Physiol; 2019 Feb; 151(2):214-230. PubMed ID: 30674563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of temperature-induced hERG channel blockade variation by drugs.
    Kauthale RR; Dadarkar SS; Husain R; Karande VV; Gatne MM
    J Appl Toxicol; 2015 Jul; 35(7):799-805. PubMed ID: 25348819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
    Paul AA; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dimethyl sulfoxide effects on hERG channels expressed in HEK293 cells.
    Du X; Lu D; Daharsh ED; Yao A; Dewoody R; Yao JA
    J Pharmacol Toxicol Methods; 2006; 54(2):164-72. PubMed ID: 16782359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evolutionarily conserved residue A653 plays a key role in HERG channel closing.
    Stepanovic SZ; Potet F; Petersen CI; Smith JA; Meiler J; Balser JR; Kupershmidt S
    J Physiol; 2009 Jun; 587(Pt 11):2555-66. PubMed ID: 19406877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton block of the pore underlies the inhibition of hERG cardiac K+ channels during acidosis.
    Van Slyke AC; Cheng YM; Mafi P; Allard CR; Hull CM; Shi YP; Claydon TW
    Am J Physiol Cell Physiol; 2012 Jun; 302(12):C1797-806. PubMed ID: 22517356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced inhibitory effect of acidosis on hERG potassium channels that incorporate the hERG1b isoform.
    Du CY; El Harchi A; McPate MJ; Orchard CH; Hancox JC
    Biochem Biophys Res Commun; 2011 Feb; 405(2):222-7. PubMed ID: 21219869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dofetilide block involves interactions with open and inactivated states of HERG channels.
    Weerapura M; Hébert TE; Nattel S
    Pflugers Arch; 2002 Feb; 443(4):520-31. PubMed ID: 11907818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.